Utah Medical Products
UTMD
78 hedge funds and large institutions have $203M invested in Utah Medical Products in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
57% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 21
11% more capital invested
Capital invested by funds: $182M → $203M (+$20.6M)
5% more funds holding
Funds holding: 74 → 78 (+4)
0.45% more ownership
Funds ownership: 66.68% → 67.14% (+0.45%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$3.4M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$1.65M |
| 3 |
Renaissance Technologies
New York
|
+$1.48M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.08M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$835K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$4.93M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$2.87M |
| 3 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$888K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$702K |
| 5 |
Bank of New York Mellon
New York
|
-$353K |
UTMD Hedge Fund Activity: Q4 2017 in Review
78 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2017, worth a combined $203M — up 11% from $182M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new UTMD positions and 6 closed out — a net gain of 4 holders — while 33 added to existing stakes and 21 trimmed.
The largest buyer was THB Asset Management, opening a new position worth an estimated $3.4M. The largest seller was American Century Companies, exiting entirely with an estimated $4.93M sold.
- 78 institutional investors held Utah Medical Products (UTMD) as of Q4 2017, up from 74 in Q3 2017.
- Funds reported $203M of Utah Medical Products stock for Q4 2017, up 11% quarter-over-quarter.
- 10 funds opened new Utah Medical Products positions in Q4 2017 and 6 closed out, a net change of +4 holders.
- The largest Utah Medical Products buyer in Q4 2017 was THB Asset Management, an estimated $3.4M added.
- The largest Utah Medical Products seller in Q4 2017 was American Century Companies, an estimated $4.93M sold.
Based on aggregated 13F filings for Q4 2017.